Skip to main content
. 2020 Oct 26;5(43):28319–28332. doi: 10.1021/acsomega.0c04300

Figure 4.

Figure 4

(A) XRD diffraction patterns of CLF of NAR + SFN: (a) 15:0:1 blank liposome, (b) 15:4:1 blank liposome, (c) 15:9:1 blank liposome, (d) 15:4:1 NAR + SFN liposome, and (e) combination of pure drugs NAR + SFN. (B) XRD diffraction patterns of CLF of NAR + PEITC: (a) 15:0:1 blank liposome, (b) 15:4:1 blank liposome, (c) 15:9:1 blank liposome, (d) 15:4:1 NAR + PEITC liposome, and (e) combination of pure drugs NAR + PEITC.